Tecentriq Hybreza 1875 mg / 30,000 UNT in 15 mL Injection
RxNorm 2693899
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2693899 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tecentriq Hybreza 1875 mg / 30,000 UNT in 15 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
15 mL atezolizumab-tqjs 125 mg/ML / hyaluronidase-tqjs 2000 UNT/ML Injection [Tecentriq Hybreza]
(Atom ID: 12916447)
SYPrescribable
Synonym (SY):
Tecentriq Hybreza (atezolizumab-hyaluronidase-tqjs 1875 mg / 30,000 UNT) per 15 mL Injection
(Atom ID: 12916449)
PSNPrescribable